Yep remdesivir was pretty much approved by TGA based on the regulatory approval in Europe. We copy the other regulators.
Regulatory status
This product is considered a new chemical entity for Australian regulatory purposes.
At the time the TGA considered this application, a similar application had been approved
in Japan, Singapore and the European Union (EU), and was under consideration in the
United States of America (USA) and Canada (see Table 1).
On 3 July 2020, the European Commission granted a conditional marketing
authorisation;16 for remdesivir, for the treatment of COVID-19 in adults and adolescents
from 12 years of age (weighing at least 40 kg) with pneumonia who require supplemental
oxygen.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-5435
-
- There are more pages in this discussion • 12,386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B |
Open | High | Low | Value | Volume |
$1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 31000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99680 | 1.150 |
4 | 178484 | 1.145 |
3 | 40155 | 1.140 |
1 | 23155 | 1.135 |
3 | 88145 | 1.130 |
Price($) | Vol. | No. |
---|---|---|
1.155 | 31000 | 2 |
1.160 | 77919 | 3 |
1.165 | 2000 | 1 |
1.170 | 45455 | 3 |
1.175 | 49449 | 5 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |